Reference Source

1,150 records

How long has this drug been in shortage?

Across 1,150 records covering 1,147 package NDCs, days in shortage runs from 69 (0409-0801-01) to 5421 (24 package NDCs), and 1209 is the most common — 98 of them. Every value is transcribed from the source that states it and carries the sentence it was taken from: 285 sources across 1 site, last checked 2026-11-01, due for re-check by 2026-11-04. Every record has a page of its own, quoting the line that states it.

Records1,150
Sources285
Verified
Review by
LicenceopenFDA drug shortage data is a U.S. government work and is in the public domain. No source-licence question arises; each record still cites the specific API query and retrieval date it came from.

About this data

For every package FDA currently lists as in shortage: how long that shortage entry has been open (from openFDA's own `initial_posting_date` to today), what FDA says the package's supply is right now, and any recovery estimate FDA has given. What FDA itself publishes, checked directly on 2026-09-01 rather than assumed: the shortage list page (accessdata.fda.gov/scripts/drugshortages) shows which drugs are short and why and carries no date at all, while each per-drug detail page adds a single 'Date first posted' for the whole drug. Neither prints an elapsed duration, and neither gives the date per manufacturer. openFDA does — where several manufacturers report a shortage of the same drug, each carries its own posting date, and FDA's page shows only the earliest of them. Cross-checked across 30 drugs against those detail pages: 30 of 30 agreed, and in all 10 multi-manufacturer cases FDA's single date was exactly the earliest of ours. The underlying facts are FDA's own public-domain data; the duration is a computation over them that nobody publishes maintained, because it changes every day and hand-updating it was never worth the effort. A scheduled refetch of the same public API keeps it current for free. Read the duration next to `availability`, and do not read it alone: a shortage entry stays 'Current' until FDA resolves the whole shortage, so 63.8% of listed packages (746 of 1,169, measured 2026-09-01) are marked 'Available' even while their entry has been open for years — the median entry has been open 1,721 days and 1,118 of 1,169 have been open more than 1,000. Records cite a per-drug, per-manufacturer API query rather than a page offset, because openFDA's result ordering rotates daily and an offset URL stops containing its own record — see sources.txt. Source: https://api.fda.gov/drug/shortages.json (openFDA, no API key required at this volume). This is a monitored dataset, not a static page — stale_after_days is short and a build should re-run the fetch on a schedule rather than once.

The data

Package NDCGeneric nameManufacturerStatusAvailability nowInitial posting dateLast update dateDays in shortageDosage formTherapeutic categoryFDA noteReason for shortage
0009-0274-01Methylprednisolone Acetate InjectionPfizer Inc.CurrentAvailable12/15/202110/21/20261785InjectionRheumatology
0009-0280-02Methylprednisolone Acetate InjectionPfizer Inc.CurrentUnavailable12/15/202110/21/20261785InjectionRheumatologyNext Delivery: November 2026; Estimated Recovery: December 2026Demand increase for the drug
0009-0280-03Methylprednisolone Acetate InjectionPfizer Inc.CurrentLimited Availability12/15/202110/21/20261785InjectionRheumatologyLimited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0009-0280-51Methylprednisolone Acetate InjectionPfizer Inc.CurrentLimited Availability12/15/202110/21/20261785InjectionRheumatologyLimited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026Demand increase for the drug
0009-0280-52Methylprednisolone Acetate InjectionPfizer Inc.CurrentAvailable12/15/202110/21/20261785InjectionRheumatology
0009-0306-02Methylprednisolone Acetate InjectionPfizer Inc.CurrentAvailable12/15/202110/21/20261785InjectionRheumatology
0009-0306-12Methylprednisolone Acetate InjectionPfizer Inc.CurrentAvailable12/15/202110/21/20261785InjectionRheumatology
0009-0775-26Clindamycin Phosphate InjectionPfizer Inc.CurrentUnavailable03/21/202310/21/20261324InjectionAnti-InfectiveNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0009-0870-26Clindamycin Phosphate InjectionPfizer Inc.CurrentUnavailable03/21/202310/21/20261324InjectionAnti-InfectiveNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0009-0902-18Clindamycin Phosphate InjectionPfizer Inc.CurrentUnavailable03/21/202310/21/20261324InjectionAnti-InfectiveNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0009-3073-01Methylprednisolone Acetate InjectionPfizer Inc.CurrentLimited Availability12/15/202110/21/20261785InjectionRheumatologyLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026Demand increase for the drug
0009-3073-03Methylprednisolone Acetate InjectionPfizer Inc.CurrentLimited Availability12/15/202110/21/20261785InjectionRheumatologyLimited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0009-3073-22Methylprednisolone Acetate InjectionPfizer Inc.CurrentAvailable12/15/202110/21/20261785InjectionRheumatology
0009-3073-23Methylprednisolone Acetate InjectionPfizer Inc.CurrentAvailable12/15/202110/21/20261785InjectionRheumatology
0009-3475-01Methylprednisolone Acetate InjectionPfizer Inc.CurrentLimited Availability12/15/202110/21/20261785InjectionRheumatologyLimited Supply Available. Next Delivery and Estimated Recovery: December 2026Demand increase for the drug
0009-3475-03Methylprednisolone Acetate InjectionPfizer Inc.CurrentLimited Availability12/15/202110/21/20261785InjectionRheumatologyLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0037-0678-96Cromolyn Sodium ConcentrateMylan Specialty, a Viatris CompanyCurrentAvailable11/03/202311/03/20261097ConcentratePulmonary/Allergy
0053-6871-00Desmopressin Acetate SprayFerringCurrentUnavailable03/12/202105/01/20262063SprayHematologyEstimated recovery: TBDRequirements related to complying with good manufacturing practices
0054-0370-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202310/14/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-0371-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202310/14/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-0372-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202310/14/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-0373-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202310/14/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-0374-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202310/14/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-0375-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202310/14/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-0660-25Lisdexamfetamine Dimesylate CapsuleHikma Pharmaceuticals USA, Inc.CurrentLimited Availability07/14/202305/12/20261209CapsulePsychiatryAvailable on allocationShortage of an active ingredient
0054-3294-46Furosemide Oral SolutionHikma Pharmaceuticals USA, Inc.CurrentAvailable03/31/202610/27/2026218Oral SolutionCardiovascular
0054-3294-50Furosemide Oral SolutionHikma Pharmaceuticals USA, Inc.CurrentAvailable03/31/202610/27/2026218Oral SolutionCardiovascular
0054-3298-63Furosemide Oral SolutionHikma Pharmaceuticals USA, Inc.CurrentAvailable03/31/202610/27/2026218Oral SolutionCardiovascular
0068-0597-01Rifampin InjectionSanofi-Aventis U.S. LLCCurrentUnavailable02/17/202109/18/20262086InjectionAnti-InfectiveDiscontinuation of the manufacture of the drugDiscontinuation of the manufacture of the drug
0093-0832-01Clonazepam TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable03/10/202311/02/20261335TabletNeurology
0093-0832-05Clonazepam TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable03/10/202311/02/20261335TabletNeurology
0093-3212-01Clonazepam TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable03/10/202311/02/20261335TabletNeurology
0093-3212-05Clonazepam TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable03/10/202311/02/20261335TabletNeurology
0093-3213-01Clonazepam TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable03/10/202311/02/20261335TabletNeurology
0093-3213-05Clonazepam TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable03/10/202311/02/20261335TabletNeurology
0143-9144-02Liraglutide InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable07/18/202310/14/20261205InjectionEndocrinology/Metabolism
0143-9144-03Liraglutide InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable07/18/202310/14/20261205InjectionEndocrinology/Metabolism
0143-9250-10Rocuronium Bromide InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable02/15/202310/14/20261358InjectionAnesthesiaAdditional lots will be available. Product will be made available as it is released.
0143-9251-10Rocuronium Bromide InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable02/15/202310/14/20261358InjectionAnesthesiaAdditional lots will be available. Product will be made available as it is released.
0143-9252-25Dopamine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable11/06/201710/14/20263285InjectionCardiovascularProduct temporarily on backorder. Additional lots will be available in the February 2027 timeframe.Demand increase for the drug
0143-9254-25Dopamine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable11/06/201710/14/20263285InjectionCardiovascularAdditional lots will be available in the November 2026 timeframe. Product will be made available as it is released.Demand increase for the drug
0143-9310-10Etomidate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable10/05/202210/14/20261491InjectionAnesthesiaNovaplus label
0143-9311-10Etomidate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable10/05/202210/14/20261491InjectionAnesthesiaNovaplus label
0143-9391-10Remifentanil Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/28/202210/14/20261590InjectionAnalgesia/AddictionEstimated recovery: TBDDemand increase for the drug
0143-9392-10Remifentanil Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/28/202210/14/20261590InjectionAnalgesia/AddictionEstimated recovery: TBDDemand increase for the drug
0143-9393-10Remifentanil Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/28/202210/14/20261590InjectionAnalgesia/AddictionEstimated recovery: TBDDemand increase for the drug
0143-9506-10Etomidate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable10/05/202210/14/20261491InjectionAnesthesiaAdditional product will be made available as it is released.
0143-9507-10Etomidate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable10/05/202210/14/20261491InjectionAnesthesiaAdditional product will be made available as it is released.
0143-9519-10Methotrexate Sodium InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable03/13/202310/14/20261332InjectionRheumatologyAdditional lots will be available in the October 2026 timeframe. Product will be made available as it is released.Demand increase for the drug
0143-9530-01Ifosfamide InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/12/202610/14/2026145InjectionOncologyAdditional lots will be available in the November 2026 timeframe. Product will be made available as it is released.Demand increase for the drug
0143-9531-01Ifosfamide InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/12/202610/14/2026145InjectionOncologyAdditional lots will be available in the November 2026 timeframe. Product will be made available as it is released.Demand increase for the drug
0143-9532-25Dexmedetomidine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable04/10/202010/14/20262399InjectionAnesthesiaAdditional product will be made available as it is released.
0143-9575-10Lidocaine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable06/13/201810/14/20263066InjectionAnesthesiaAdditional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
0143-9577-10Lidocaine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable06/13/201810/14/20263066InjectionAnesthesiaAdditional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
0143-9594-25Lidocaine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable06/13/201810/14/20263066InjectionAnesthesiaAdditional lots are scheduled to be manufactured. Product will be made available as it is released.
0143-9595-25Lidocaine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/13/201810/14/20263066InjectionAnesthesiaProduct temporarily on backorder. Additional lots will be available in the November 2026 timeframe.Demand increase for the drug
0143-9606-01Azacitidine InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable12/18/202010/14/20262147InjectionOncologyProduct temporarily on backorder. Additional lots will be available the end of October 2026.Demand increase for the drug
0143-9785-10Valproate Sodium InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable12/30/202010/14/20262135InjectionNeurologyAdditional lots will be available. Product will be made available as it is released.
0143-9830-01Methotrexate Sodium InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable03/13/202310/14/20261332InjectionRheumatologyAdditional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available.Demand increase for the drug
0143-9872-10Propranolol Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable10/31/202310/14/20261100InjectionCardiovascularEstimated recovery: TBDShortage of an active ingredient
0143-9930-10Cefotaxime Sodium Powder, for SolutionHikma Pharmaceuticals USA, Inc.CurrentUnavailable02/17/201510/14/20264278Powder, For SolutionAnti-InfectiveEstimated recovery: TBDDemand increase for the drug
0143-9931-25Cefotaxime Sodium Powder, for SolutionHikma Pharmaceuticals USA, Inc.CurrentUnavailable02/17/201510/14/20264278Powder, For SolutionAnti-InfectiveEstimated recovery: TBDDemand increase for the drug
0143-9933-25Cefotaxime Sodium Powder, for SolutionHikma Pharmaceuticals USA, Inc.CurrentUnavailable02/17/201510/14/20264278Powder, For SolutionAnti-InfectiveEstimated recovery: TBDDemand increase for the drug
0143-9935-01Cefotaxime Sodium Powder, for SolutionHikma Pharmaceuticals USA, Inc.CurrentUnavailable02/17/201510/14/20264278Powder, For SolutionAnti-InfectiveEstimated recovery: TBDDemand increase for the drug
0169-2800-15Liraglutide InjectionNovo Nordisk, Inc.CurrentLimited Availability07/18/202309/22/20261205InjectionEndocrinology/MetabolismProduct will be available until discontinuation in January 2027Discontinuation of the manufacture of the drug
0169-4060-12Liraglutide InjectionNovo Nordisk, Inc.CurrentLimited Availability07/18/202309/22/20261205InjectionEndocrinology/MetabolismEstimated shortage duration: TBDDelay in shipping of the drug
0169-4060-13Liraglutide InjectionNovo Nordisk, Inc.CurrentLimited Availability07/18/202309/22/20261205InjectionEndocrinology/MetabolismEstimated shortage duration: TBDDelay in shipping of the drug
0185-0842-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSandoz Inc.CurrentAvailable10/12/202210/21/20261484TabletPsychiatry
0185-0853-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSandoz Inc.CurrentAvailable10/12/202210/21/20261484TabletPsychiatry
0185-2098-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSandoz Inc.CurrentAvailable10/12/202210/21/20261484TabletPsychiatry
0185-2099-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSandoz Inc.CurrentAvailable10/12/202210/21/20261484TabletPsychiatry
0264-1510-31Dextrose Monohydrate 5% InjectionB. Braun Medical Inc.CurrentAvailable02/14/202210/19/20261724InjectionEndocrinology/Metabolism
0264-1510-32Dextrose Monohydrate 5% InjectionB. Braun Medical Inc.CurrentAvailable02/14/202210/19/20261724InjectionEndocrinology/Metabolism
0264-1933-10Amino Acid InjectionB. Braun Medical Inc.CurrentAvailable12/08/202010/19/20262157InjectionGastroenterology
0264-2101-00Sterile Water IrrigantB. Braun Medical Inc.CurrentAvailable04/28/202310/19/20261286IrrigantGastroenterology
0264-2101-10Sterile Water IrrigantB. Braun Medical Inc.CurrentAvailable04/28/202310/19/20261286IrrigantGastroenterology
0264-4500-00Amino Acid InjectionB. Braun Medical Inc.CurrentAvailable12/08/202010/19/20262157InjectionGastroenterology
0264-4500-05Amino Acid InjectionB. Braun Medical Inc.CurrentAvailable12/08/202010/19/20262157InjectionGastroenterology
0264-7387-50Dextrose Monohydrate 70% InjectionB. Braun Medical Inc.CurrentAvailable10/11/202410/19/2026754InjectionEndocrinology/Metabolism
0264-7510-00Dextrose Monohydrate 5% InjectionB. Braun Medical Inc.CurrentAvailable02/14/202210/19/20261724InjectionEndocrinology/Metabolism
0264-7510-10Dextrose Monohydrate 5% InjectionB. Braun Medical Inc.CurrentAvailable02/14/202210/19/20261724InjectionEndocrinology/Metabolism
0264-7510-20Dextrose Monohydrate 5% InjectionB. Braun Medical Inc.CurrentAvailable02/14/202210/19/20261724InjectionEndocrinology/Metabolism
0264-7520-00Dextrose Monohydrate 10% InjectionB. Braun Medical Inc.CurrentAvailable03/01/202210/19/20261709InjectionEndocrinology/Metabolism
0264-7520-10Dextrose Monohydrate 10% InjectionB. Braun Medical Inc.CurrentAvailable03/01/202210/19/20261709InjectionEndocrinology/Metabolism
0264-7520-20Dextrose Monohydrate 10% InjectionB. Braun Medical Inc.CurrentAvailable03/01/202210/19/20261709InjectionEndocrinology/Metabolism
0264-9594-10Lidocaine Hydrochloride InjectionB. Braun Medical Inc.CurrentAvailable10/25/201710/19/20263297InjectionCardiovascular
0264-9594-20Lidocaine Hydrochloride InjectionB. Braun Medical Inc.CurrentAvailable10/25/201710/19/20263297InjectionCardiovascular
0264-9598-20Lidocaine Hydrochloride InjectionB. Braun Medical Inc.CurrentAvailable10/25/201710/19/20263297InjectionCardiovascular
0264-9872-00Heparin Sodium InjectionB. Braun Medical Inc.CurrentLimited Availability11/14/201710/19/20263277InjectionHematologyEstimated recovery: late Q4 2026; Manufacturing delaysOther
0264-9872-10Heparin Sodium InjectionB. Braun Medical Inc.CurrentLimited Availability11/14/201710/19/20263277InjectionHematologyEstimated recovery: late Q4 2026; Manufacturing delaysOther
0338-0004-02Sterile Water IrrigantBaxter HealthcareCurrentAvailable04/28/202311/03/20261286IrrigantGastroenterology
0338-0004-03Sterile Water IrrigantBaxter HealthcareCurrentAvailable04/28/202311/03/20261286IrrigantGastroenterology
0338-0004-04Sterile Water IrrigantBaxter HealthcareCurrentLimited Availability04/28/202310/16/20261286IrrigantGastroenterologyEstimated Recovery: January 2027Other
0338-0017-02Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-03Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-10Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-11Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentUnavailable02/14/202211/03/20261724InjectionEndocrinology/MetabolismEstimated recovery: November 2026Demand increase for the drug
0338-0017-18Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-31Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-38Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-41Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0017-48Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentUnavailable02/14/202211/03/20261724InjectionEndocrinology/MetabolismEstimated recovery: December 2026Demand increase for the drug
0338-0023-02Dextrose Monohydrate 10% InjectionBaxter HealthcareCurrentAvailable03/01/202211/03/20261709InjectionEndocrinology/Metabolism
0338-0023-03Dextrose Monohydrate 10% InjectionBaxter HealthcareCurrentAvailable03/01/202211/03/20261709InjectionEndocrinology/Metabolism
0338-0023-04Dextrose Monohydrate 10% InjectionBaxter HealthcareCurrentAvailable03/01/202211/03/20261709InjectionEndocrinology/Metabolism
0338-0069-10Ketorolac Tromethamine InjectionBaxter HealthcareCurrentUnavailable06/06/201811/03/20263073InjectionAnalgesia/AddictionEstimated recovery: December 2026Demand increase for the drug
0338-0070-10Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0072-25Ketorolac Tromethamine InjectionBaxter HealthcareCurrentAvailable06/06/201811/03/20263073InjectionAnalgesia/Addiction
0338-0074-30Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable07/20/202611/03/2026107InjectionEndocrinology/Metabolism
0338-0078-20Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0409-03Lidocaine Hydrochloride InjectionBaxter HealthcareCurrentAvailable10/25/201711/03/20263297InjectionCardiovascular
0338-0411-02Lidocaine Hydrochloride InjectionBaxter HealthcareCurrentAvailable10/25/201711/03/20263297InjectionCardiovascular
0338-0431-03Heparin Sodium InjectionBaxter HealthcareCurrentLimited Availability11/14/201710/16/20263277InjectionHematologyEstimated recovery: December 2026Demand increase for the drug
0338-0433-04Heparin Sodium InjectionBaxter HealthcareCurrentAvailable11/14/201711/03/20263277InjectionHematology
0338-0499-06Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-0502-03Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-0502-06Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-0551-11Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0551-18Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-0644-03Amino Acid InjectionBaxter HealthcareCurrentUnavailable12/08/202011/03/20262157InjectionGastroenterologyEstimated recovery: December 2026Shortage of an inactive ingredient component
0338-0644-04Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-0644-06Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-0719-06Dextrose Monohydrate 70% InjectionBaxter HealthcareCurrentAvailable10/11/202411/03/2026754InjectionEndocrinology/Metabolism
0338-1005-02Dopamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201711/03/20263285InjectionCardiovascular
0338-1005-03Dopamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201711/03/20263285InjectionCardiovascular
0338-1007-02Dopamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201711/03/20263285InjectionCardiovascular
0338-1007-03Dopamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201710/16/20263285InjectionCardiovascular
0338-1055-48Metronidazole InjectionBaxter HealthcareCurrentAvailable01/13/202211/03/20261756InjectionAnti-Infective
0338-1073-02Dobutamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201711/03/20263285InjectionCardiovascular
0338-1075-02Dobutamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201711/03/20263285InjectionCardiovascular
0338-1077-02Dobutamine Hydrochloride InjectionBaxter HealthcareCurrentAvailable11/06/201711/03/20263285InjectionCardiovascular
0338-1130-03Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-1130-04Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-1130-06Amino Acid InjectionBaxter HealthcareCurrentAvailable12/08/202011/03/20262157InjectionGastroenterology
0338-3410-50Clindamycin Phosphate InjectionBaxter HealthcareCurrentAvailable03/21/202311/03/20261324InjectionAnti-Infective
0338-3612-50Clindamycin Phosphate InjectionBaxter HealthcareCurrentAvailable03/21/202311/03/20261324InjectionAnti-Infective
0338-3814-50Clindamycin Phosphate InjectionBaxter HealthcareCurrentLimited Availability03/21/202310/16/20261324InjectionAnti-InfectiveEstimated recovery: December 2026Other
0338-3991-01Ifosfamide InjectionBaxter HealthcareCurrentAvailable06/12/202611/03/2026145InjectionOncology
0338-3993-01Ifosfamide InjectionBaxter HealthcareCurrentAvailable06/12/202611/03/2026145InjectionOncology
0338-9545-50Clindamycin Phosphate InjectionBaxter HealthcareCurrentAvailable03/21/202311/03/20261324InjectionAnti-Infective
0338-9549-50Clindamycin Phosphate InjectionBaxter HealthcareCurrentAvailable03/21/202310/16/20261324InjectionAnti-Infective
0338-9553-50Clindamycin Phosphate InjectionBaxter HealthcareCurrentAvailable03/21/202311/03/20261324InjectionAnti-Infective
0338-9555-24Dexmedetomidine Hydrochloride InjectionBaxter HealthcareCurrentAvailable04/10/202011/03/20262399InjectionAnesthesia
0338-9557-12Dexmedetomidine Hydrochloride InjectionBaxter HealthcareCurrentAvailable04/10/202011/03/20262399InjectionAnesthesia
0338-9664-40Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0338-9666-35Dextrose Monohydrate 5% InjectionBaxter HealthcareCurrentAvailable02/14/202211/03/20261724InjectionEndocrinology/Metabolism
0378-4415-01Flurazepam Hydrochloride CapsuleRising Pharma Holdings, Inc.CurrentUnavailable08/03/202209/01/20261554CapsuleNeurologyAnticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.Regulatory delay
0378-4430-01Flurazepam Hydrochloride CapsuleRising Pharma Holdings, Inc.CurrentUnavailable08/03/202209/01/20261554CapsuleNeurologyAnticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.Regulatory delay
0378-6854-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0378-6855-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0378-6856-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0378-6857-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0378-6858-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0378-6859-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0378-6860-77Lisdexamfetamine Dimesylate CapsuleMylan Pharmaceuticals Inc., a Viatris CompanyCurrentAvailable07/14/202311/03/20261209CapsulePsychiatry
0406-5111-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-5112-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-5113-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-5114-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-5115-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-5116-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-5117-01Lisdexamfetamine Dimesylate CapsuleSpecGx LLCCurrentAvailable07/14/202308/20/20261209CapsulePsychiatry
0406-8884-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSpecGx LLCCurrentAvailable10/12/202208/20/20261484TabletPsychiatry
0406-8885-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSpecGx LLCCurrentAvailable10/12/202208/20/20261484TabletPsychiatry
0406-8891-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSpecGx LLCCurrentLimited Availability10/12/202208/20/20261484TabletPsychiatryEstimated recovery: TBDDemand increase for the drug
0406-8892-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSpecGx LLCCurrentLimited Availability10/12/202208/20/20261484TabletPsychiatryEstimated recovery: TBDDemand increase for the drug
0406-8893-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSpecGx LLCCurrentAvailable10/12/202208/20/20261484TabletPsychiatry
0406-8894-01Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletSpecGx LLCCurrentLimited Availability10/12/202208/20/20261484TabletPsychiatryEstimated recovery: TBDDemand increase for the drug
0409-0001-25Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability04/02/202010/29/20262407InjectionAnesthesiaLimited Supply Available. Next Delivery: December 2026; Estimated Recovery: March 2027Demand increase for the drug
0409-0024-10Sterile Water InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/23/202110/29/20261807InjectionOther
0409-0025-10Dobutamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-0042-12Dopamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-0151-10Dobutamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-0152-24Metronidazole InjectionInfoRLife SACurrentLimited Availability01/13/202211/02/20261756InjectionAnti-InfectiveLabeler: Hospira Inc.Other
0409-0155-02Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-0525-25Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesiaHistorical NDC: 0409-1610-50
0409-0801-01Pentostatin InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable08/27/202610/21/202669InjectionOncologyNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0409-1005-20Heparin Sodium InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/14/201710/21/20263277InjectionHematology
0409-1100-10Dobutamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-1159-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1159-02Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1160-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1162-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1162-02Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1163-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1165-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1165-02Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1174-10Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-1176-30Meperidine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable05/30/202510/21/2026523InjectionAnalgesia/Addiction
0409-1178-30Meperidine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable05/30/202510/21/2026523InjectionAnalgesia/Addiction
0409-1181-30Meperidine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable05/30/202510/21/2026523InjectionAnalgesia/Addiction
0409-1209-01Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/22/201210/21/20265369InjectionAnesthesiaNext Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-1283-31Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-1283-37Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable10/31/201710/21/20263291InjectionAnalgesia/AddictionNext Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-1304-31Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-1312-30Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-1312-36Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability10/31/201710/21/20263291InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-1323-05Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-1403-10Rocuronium Bromide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/15/202310/21/20261358InjectionAnesthesia
0409-1434-01Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-1454-20Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-1530-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-1541-10Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-1596-10Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-1630-10Atropine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability01/01/201210/21/20265421InjectionAnesthesiaNext Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-1638-02Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202009/08/20262399InjectionAnesthesia
0409-1660-20Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202009/21/20262399InjectionAnesthesia
0409-1660-50Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-1746-10Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-1746-30Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-1749-10Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-1749-29Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-1752-50Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/20/201810/29/20263179InjectionAnesthesiaLimited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-1755-50Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-1761-10Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/21/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-1761-62Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnalgesia/Addiction
0409-1805-01Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable11/01/201710/21/20263290InjectionAnalgesia/AddictionNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-1858-12Dopamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-1890-01Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-1890-23Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability10/31/201710/21/20263291InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-1891-01Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-1893-01Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable10/31/201710/21/20263291InjectionAnalgesia/AddictionDiscontinuation of the manufacture of the drugDiscontinuation of the manufacture of the drug
0409-1896-20Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable10/31/201710/21/20263291InjectionAnalgesia/AddictionNext Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-1985-30Lorazepam InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability05/03/201810/21/20263107InjectionNeurologyLimited Supply Available. Next Delivery and Estimated Recovery: June 2027Demand increase for the drug
0409-2022-01Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable10/31/201710/21/20263291InjectionAnalgesia/AddictionNext Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-2066-05Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-2222-12Heparin Sodium InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/14/201710/21/20263277InjectionHematology
0409-2253-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesiaHistorical NDC: 0409-1582-29
0409-2253-25Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesiaHistorical NDC: 0409-1582-29
0409-2305-05Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability04/02/202010/29/20262407InjectionAnesthesiaLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027Demand increase for the drug
0409-2305-17Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability04/02/202010/29/20262407InjectionAnesthesiaNext Estimated Delivery and Estimated Recovery: December 2026Demand increase for the drug
0409-2305-50Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/02/202010/29/20262407InjectionAnesthesia
0409-2308-01Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable04/02/202010/29/20262407InjectionAnesthesiaNext Delivery: November 2026; Estimated Recovery: December 2026Demand increase for the drug
0409-2308-02Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable04/02/202010/29/20262407InjectionAnesthesiaNext Delivery: November 2026; Estimated Recovery: December 2026Demand increase for the drug
0409-2308-49Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/02/202010/29/20262407InjectionAnesthesia
0409-2308-50Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/02/202010/29/20262407InjectionAnesthesia
0409-2344-01Dobutamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-2344-02Dobutamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-2344-88Dobutamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable11/06/201710/21/20263285InjectionCardiovascularNext Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-2510-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-2587-05Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable04/02/202010/29/20262407InjectionAnesthesiaNext Delivery: January 2027; Estimated Recovery: March 2027Demand increase for the drug
0409-2596-03Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/02/202010/29/20262407InjectionAnesthesia
0409-2596-05Midazolam Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/02/202010/29/20262407InjectionAnesthesia
0409-2634-01Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-2634-05Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-2634-50Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-2815-01Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-3177-01Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/22/201210/21/20265369InjectionAnesthesiaNext Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-3178-01Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-3178-02Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/22/201210/21/20265369InjectionAnesthesiaNext Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3178-03Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3181-01Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availalbility02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3182-01Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/22/201210/21/20265369InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0409-3182-02Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3182-03Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3183-01Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability02/22/201210/21/20265369InjectionAnesthesiaLimited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3189-10Rocuronium Bromide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/15/202310/21/20261358InjectionAnesthesia
0409-3299-05Sodium Acetate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/03/201610/21/20263927InjectionEndocrinology/Metabolism
0409-3299-06Sodium Acetate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/03/201610/21/20263927InjectionEndocrinology/Metabolism
0409-3299-25Sodium Acetate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/03/201610/21/20263927InjectionEndocrinology/Metabolism
0409-3299-26Sodium Acetate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/03/201610/21/20263927InjectionEndocrinology/Metabolism
0409-3301-10Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentLimited Availability04/10/202010/21/20262399InjectionAnesthesiaLimited Supply Available. Next Delivery and Estimated Recovery: December 2026Other
0409-3365-10Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-3382-21Sufentanil Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability05/03/202210/21/20261646InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-3613-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-3793-01Ketorolac Tromethamine InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable03/26/201810/21/20263145InjectionAnalgesia/AddictionNext Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3795-01Ketorolac Tromethamine InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable03/26/201810/21/20263145InjectionAnalgesia/AddictionNext Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3796-01Ketorolac Tromethamine InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable03/26/201810/21/20263145InjectionAnalgesia/AddictionNext Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-3812-01Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-3814-12Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable10/31/201710/21/20263291InjectionAnalgesia/Addiction
0409-3815-12Morphine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability10/31/201710/21/20263291InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-3977-03Sterile Water InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable12/03/202110/29/20261797InjectionOther
0409-4208-10Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-4264-01Hydromorphone Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability11/01/201710/21/20263290InjectionAnalgesia/AddictionNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-4275-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/22/201210/21/20265369InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0409-4276-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4276-02Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4277-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4277-02Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4278-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4279-02Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4282-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4282-02Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4283-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4596-20Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-4713-02Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4713-32Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/22/201210/21/20265369InjectionAnesthesiaNext Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-4776-01Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-4887-10Sterile Water InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/23/202110/29/20261807InjectionOther
0409-4887-20Sterile Water InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/23/202110/29/20261807InjectionOther
0409-4887-50Sterile Water InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/23/202110/29/20261807InjectionOther
0409-4887-99Sterile Water InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/23/202110/29/20261807InjectionOther
0409-5010-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-5160-10Rocuronium Bromide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/15/202310/21/20261358InjectionAnesthesia
0409-5555-01Sodium Bicarbonate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Supply Available. Next Delivery and Estimated Recovery: June 202703/01/201710/21/20263535InjectionEndocrinology/MetabolismLimited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-5555-02Sodium Bicarbonate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability03/01/201710/21/20263535InjectionEndocrinology/MetabolismLimited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027Demand increase for the drug
0409-5738-10Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-5820-01Dopamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable11/06/201710/21/20263285InjectionCardiovascular
0409-6102-02Furosemide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/07/202010/21/20262402InjectionCardiovascular
0409-6102-04Furosemide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/07/202010/21/20262402InjectionCardiovascular
0409-6102-10Furosemide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable04/07/202010/21/20262402InjectionCardiovascular
0409-6102-25Furosemide InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable04/07/202010/21/20262402InjectionCardiovascularNext Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-6102-26Furosemide InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable04/07/202010/21/20262402InjectionCardiovascularNext Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-6102-27Furosemide InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable04/07/202010/21/20262402InjectionCardiovascularNext Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing DelayOther
0409-6581-01Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnesthesia
0409-6625-14Sodium Bicarbonate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable03/01/201710/21/20263535InjectionEndocrinology/Metabolism
0409-6625-35Sodium Bicarbonate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable03/01/201710/21/20263535InjectionEndocrinology/MetabolismNext Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-6648-02Dextrose Monohydrate 50% InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability01/13/202210/27/20261756InjectionEndocrinology/MetabolismNext Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing DelayOther
0409-6695-01Etomidate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable10/05/202210/21/20261491InjectionAnesthesiaNext Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-6695-02Etomidate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable10/05/202210/21/20261491InjectionAnesthesiaNext Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-7037-10Rocuronium Bromide InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/15/202310/21/20261358InjectionAnesthesia
0409-7299-25Sodium Acetate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/03/201610/21/20263927InjectionEndocrinology/Metabolism
0409-7299-73Sodium Acetate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/03/201610/21/20263927InjectionEndocrinology/Metabolism
0409-7517-16Dextrose Monohydrate 50% InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable01/13/202210/27/20261756InjectionEndocrinology/MetabolismNext Delivery: November 2026. Estimated Recovery: March 2027. Shortage per Manufacturer: Manufacturing DelayOther
0409-7535-01Bupivacaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/21/20263179InjectionAnesthesia
0409-7809-24Dopamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable11/06/201710/21/20263285InjectionCardiovascularNext Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-7838-24Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-7853-24Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202010/21/20262399InjectionAnesthesia
0409-7875-12Dexmedetomidine Hydrochloride InjectionPfizer Inc.CurrentAvailable04/10/202009/21/20262399InjectionAnesthesia
0409-8126-10Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/20/201810/29/20263179InjectionAnalgesia/Addiction
0409-9042-01Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/29/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-9042-17Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/29/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-9043-01Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/29/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-9045-01Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/29/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-9045-17Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/29/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-9046-01Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionHospira, Inc., a Pfizer CompanyCurrentUnavailable02/20/201810/29/20263179InjectionAnesthesiaNext Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing DelayOther
0409-9094-22Fentanyl Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable01/01/201210/21/20265421InjectionAnalgesia/Addiction
0409-9094-25Fentanyl Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability01/01/201210/21/20265421InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026Demand increase for the drug
0409-9094-28Fentanyl Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability01/01/201210/21/20265421InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026Demand increase for the drug
0409-9094-31Fentanyl Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability01/01/201210/21/20265421InjectionAnalgesia/AddictionLimited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026Demand increase for the drug
0409-9094-55Fentanyl Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable01/01/201210/21/20265421InjectionAnalgesia/Addiction
0409-9094-61Fentanyl Citrate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable01/01/201210/21/20265421InjectionAnalgesia/Addiction
0409-9104-20Dopamine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentLimited Availability11/06/201710/21/20263285InjectionCardiovascularLimited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing DelayOther
0409-9137-05Lidocaine Hydrochloride InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable02/22/201210/21/20265369InjectionAnesthesia
0409-9630-05Atropine Sulfate InjectionHospira, Inc., a Pfizer CompanyCurrentAvailable01/01/201210/21/20265421InjectionAnesthesia
0480-3564-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3565-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3566-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3567-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3568-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3569-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3570-01Lisdexamfetamine Dimesylate CapsuleTeva Pharmaceuticals USA, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0480-3667-20Liraglutide InjectionNovo Nordisk, Inc.CurrentAvailable07/18/202309/22/20261205InjectionEndocrinology/MetabolismDistributed by Teva
0480-3667-22Liraglutide InjectionNovo Nordisk, Inc.CurrentAvailable07/18/202309/22/20261205InjectionEndocrinology/MetabolismDistributed by Teva
0487-6105-01Sterile Water InjectionNephron Pharmaceuticals CorporationCurrentLimited Availability11/23/202108/04/20261807InjectionOtherSmall amount of inventory available with 12/31/2026 datingOther
0517-1001-25Atropine Sulfate InjectionAmerican Regent, Inc.CurrentAvailable01/01/201211/03/20265421InjectionAnesthesia
0517-1004-25Atropine Sulfate InjectionAmerican Regent, Inc.CurrentAvailable01/01/201211/03/20265421InjectionAnesthesiaOn allocation
0527-0760-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0527-0761-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0527-0763-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0527-0764-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0527-0766-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202210/15/20261484TabletPsychiatry
0527-1502-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0527-1505-37Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletLannett Company, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0527-4661-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0527-4662-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentLimited Availability07/14/202310/15/20261209CapsulePsychiatryEstimated recovery: October 2026Other
0527-4663-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentLimited Availability07/14/202310/15/20261209CapsulePsychiatryEstimated recovery: October 2026Other
0527-4664-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentLimited Availability07/14/202310/15/20261209CapsulePsychiatryEstimated recovery: October 2026Other
0527-4665-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0527-4666-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentAvailable09/20/202311/02/20261141CapsulePsychiatry
0527-4667-37Lisdexamfetamine Dimesylate CapsuleLannett Company, Inc.CurrentAvailable07/14/202311/02/20261209CapsulePsychiatry
0555-0775-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0555-0776-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0555-0777-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0555-0971-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0555-0972-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0555-0973-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentAvailable10/12/202211/02/20261484TabletPsychiatry
0555-0974-02Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletTeva Pharmaceuticals USA, Inc.CurrentLimited Availability10/12/202210/15/20261484TabletPsychiatryEstimated recovery: TBDOther
0574-2410-65Methylphenidate Film, Extended ReleaseNoven Pharmaceuticals, Inc.CurrentAvailable02/28/202510/16/2026614Film, Extended ReleasePsychiatryDistributed by Padagis US LLC
0574-2415-65Methylphenidate Film, Extended ReleaseNoven Pharmaceuticals, Inc.CurrentAvailable02/28/202510/16/2026614Film, Extended ReleasePsychiatryDistributed by Padagis US LLC
0574-2420-65Methylphenidate Film, Extended ReleaseNoven Pharmaceuticals, Inc.CurrentAvailable02/28/202510/16/2026614Film, Extended ReleasePsychiatryDistributed by Padagis US LLC
0574-2430-65Methylphenidate Film, Extended ReleaseNoven Pharmaceuticals, Inc.CurrentAvailable02/28/202510/16/2026614Film, Extended ReleasePsychiatryDistributed by Padagis US LLC
0574-4022-35Bacitracin Ophthalmic OintmentPadagis US LLCCurrentUnavailable03/03/202510/23/2026611Ophthalmic OintmentAnti-InfectiveShortage is estimated for 15 additional monthsDiscontinuation of the manufacture of the drug
0591-2888-30Hydroxocobalamin InjectionTeva Pharmaceuticals USA, Inc.CurrentUnavailable11/04/202411/02/2026730InjectionOtherEstimated recovery: mid-November 2026Other
0641-0121-25Hydromorphone Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable11/03/201710/14/20263288InjectionAnalgesia/AddictionAdditional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
0641-0367-25Dexamethasone Sodium Phosphate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable02/08/201910/14/20262826InjectionDermatologyProduct will be made available as it is released.
0641-0928-25Promethazine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable11/21/202310/14/20261079InjectionAnalgesia/AddictionAdditional lots are scheduled to be manufactured. Product will be made available as it is released.
0641-0929-25Promethazine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable11/21/202310/14/20261079InjectionAnalgesia/AddictionEstimated recovery: TBDDemand increase for the drug
0641-1495-35Promethazine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable11/21/202310/14/20261079InjectionAnalgesia/AddictionAdditional lots will be available in the November 2026 timeframe. Product will be made available as it is released.Demand increase for the drug
0641-1496-35Promethazine Hydrochloride InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable11/21/202310/14/20261079InjectionAnalgesia/AddictionAdditional lots are scheduled to be manufactured. Product will be made available as it is released.
0641-6000-10Lorazepam InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable09/05/201810/14/20262982InjectionNeurologyEstimated recovery: TBDOther
0641-6001-25Lorazepam InjectionHikma Pharmaceuticals USA, Inc.CurrentLimited Availability09/05/201810/14/20262982InjectionNeurologyAdditional lots are scheduled to be manufactured. Product will be made available as it is released.Demand increase for the drug
0641-6002-10Lorazepam InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable09/05/201810/14/20262982InjectionNeurologyEstimated recovery: TBDOther
0641-6003-25Lorazepam InjectionHikma Pharmaceuticals USA, Inc.CurrentLimited Availability09/05/201810/14/20262982InjectionNeurologyAdditional lots are scheduled to be manufactured. Product will be made available as it is released.Demand increase for the drug
0641-6019-10Morphine Sulfate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable11/03/201710/14/20263288InjectionAnalgesia/AddictionAdditional lots are scheduled to be manufactured. Product will be made available as it is released.
0641-6020-10Morphine Sulfate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable11/03/201710/14/20263288InjectionAnalgesia/AddictionAdditional lots are scheduled to be manufactured. Product will be made available as it is released.
0641-6024-10Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable12/20/202310/14/20261050InjectionAnalgesia/AddictionInventory available in vial presentations.Other
0641-6025-10Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable12/20/202310/14/20261050InjectionAnalgesia/AddictionInventory available in vial presentations.Other
0641-6026-05Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable12/20/202310/14/20261050InjectionAnalgesia/AddictionInventory available in vial presentations.Other
0641-6027-25Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable12/20/202310/14/20261050InjectionAnalgesia/AddictionAdditional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
0641-6028-25Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable12/20/202310/14/20261050InjectionAnalgesia/AddictionAdditional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
0641-6029-25Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable12/20/202310/14/20261050InjectionAnalgesia/AddictionAdditional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
0641-6030-01Fentanyl Citrate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable12/20/202310/14/20261050InjectionAnalgesia/AddictionAdditional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
0641-6039-01Morphine Sulfate InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable11/03/201710/14/20263288InjectionAnalgesia/AddictionAdditional lots will be available in the November 2026 timeframe. Product will be made available as it is released.Demand increase for the drug
0641-6040-01Morphine Sulfate InjectionHikma Pharmaceuticals USA, Inc.CurrentAvailable11/03/201710/14/20263288InjectionAnalgesia/AddictionAdditional lots are scheduled to be manufactured. Product will be made available as it is released.
0641-6041-25Ketorolac Tromethamine InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/06/201810/14/20263073InjectionAnalgesia/AddictionEstimated recovery: TBDOther
0641-6042-25Ketorolac Tromethamine InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/06/201810/14/20263073InjectionAnalgesia/AddictionEstimated recovery: TBDOther
0641-6043-25Ketorolac Tromethamine InjectionHikma Pharmaceuticals USA, Inc.CurrentUnavailable06/06/201810/14/20263073InjectionAnalgesia/AddictionEstimated recovery: TBDOther
0641-6044-25Lorazepam InjectionHikma Pharmaceuticals USA, Inc.CurrentLimited Availability09/05/201810/14/20262982InjectionNeurologyAdditional lots are scheduled to be manufactured. Product will be made available as it is released.Demand increase for the drug
0641-6045-25Lorazepam InjectionHikma Pharmaceuticals USA, Inc.CurrentLimited Availability09/05/201810/14/20262982InjectionNeurologyAdditional lots are scheduled to be manufactured. Product will be made available as it is released.Demand increase for the drug

Showing the first 400 of 1,150 records. Every record has its own page, with its source and the quoted line that states it; these list the rest.

Where this came from

Every record above links the page it was taken from and quotes the sentence that states it. These are the 285 sources this dataset was assembled from.

Machine-readable

From your own code

Same records, same quotes, without scraping the page: refsource is on PyPI and npm. Each value comes back carrying the URL it was read from and the sentence on that page that states it — .source and .quote sit on the value itself rather than in a side channel, so the checking step is available instead of skipped.

pip install refsource
refsource lookup drug-shortage-duration-tracker generic_name="Methylprednisolone Acetate Injection"

npx -y refsource lookup drug-shortage-duration-tracker generic_name="Methylprednisolone Acetate Injection"

Set your AI assistant up to use this

Two files and no account. Put this in .mcp.json at the root of your project — Claude Code, Cursor, Windsurf, VS Code and Codex all read that file — and your assistant can look this dataset up instead of recalling it. The server is remote, keyless and read-only.

{
  "mcpServers": {
    "referencesource": {
      "type": "http",
      "url": "https://referencesource.org/mcp"
    }
  }
}

Add to Cursor · or, on the command line: claude mcp add --transport http referencesource https://referencesource.org/mcp --scope project

Then one line in the project's CLAUDE.md or AGENTS.md, so the assistant knows when to reach for it:

When a question needs "FDA drug shortage duration tracker", call the referencesource MCP server at https://referencesource.org/mcp (tool `search_records`, dataset_slug `drug-shortage-duration-tracker`) instead of answering from memory — every record it returns carries its source URL and a verbatim quote from that page.

What each tool does, and the servers built over single registers: Connect your AI assistant.

1,150 records. last verified against source . due for re-check by .

Licence. openFDA drug shortage data is a U.S. government work and is in the public domain. No source-licence question arises; each record still cites the specific API query and retrieval date it came from.